Tucson-based Raytheon Missiles & Defense has been awarded a new contract to develop an air-launched hypersonic missile, as the Pentagon looks to accelerate development of the ultra-fast weapons in ...

Bristol Myers Squibb has expanded its push into radiopharma by licensing a prostate cancer therapy developed by Philochem for $350m upfront.